SIC
RCEL icon

SJS Investment Consulting’s Avita Medical RCEL Stock Holding History

SJS Investment Consulting’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141 Buy
34
+32
+1,600% +$138 ﹤0.01% 2541
2026
Q1 		$8 Buy
+2
New +$8 ﹤0.01% 2433

Other funds holding RCEL

TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SJS Investment Consulting's RCEL Position: Q2 2026 in Review

SJS Investment Consulting increased its Avita Medical (RCEL) stake by 1,600% in Q2 2026, buying an estimated $138 and bringing the position to 34 shares worth $141. The position accounts for ﹤0.01% of the portfolio, ranked #2541.

SJS Investment Consulting first reported a position in RCEL in Q1 2026 and has held it in 2 quarters since. 12 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • SJS Investment Consulting held 34 shares of Avita Medical worth $141 as of Q2 2026.
  • SJS Investment Consulting bought 32 Avita Medical shares in Q2 2026, an estimated $138.
  • Avita Medical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2541 holding.
  • SJS Investment Consulting first reported a position in Avita Medical in Q1 2026 and has held it in 2 quarters since.
  • 12 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.